A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease

Clinical trial NCT01059682 · TERMINATED

Trial details

NCT number: NCT01059682
Sponsor: Hoffmann-La Roche
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Cardiovascular Disease

Start date: 2010-01-01
Primary completion: 2011-09-01
Enrollment: 936

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.